Efficacy and Safety of Dulaglutide Monotherapy Compared With Glimepiride in East-Asian Patients With Type 2 Diabetes in a Multicentre, Double-Blind, Randomized, Parallel-Arm, Active Comparator, Phase III Trial
Variants in GLP1R, GIPR, FTO, and MC4R genes correlate with differential metabolic responses and appetite regulation
Individual risk depends on medical history, dosing, and response to treatment
Diet, activity, sleep, and stress all play roles
Although AREDS2 revealed that no significant decrease was observed in the risk of advanced AMD for lutein/zeaxanthin, subgroup analyses showed that for participants in the lowest quintile of dietary intake (mean = 696 g/day), lutein/zeaxanthin exhibited protective effects against AMD progression possibly because the lutein/zeaxanthin consumption of the individuals was similar to that of other well-nourished groups [103]